Fundz

Xnk Therapeutics Raises Sek 132 Million To Accelerate Growth

PRIVATEMar 29, 2022

Amount Raised

SEK132 Million

Round Type

Funding Round

Flemingsberg

Description

XNK Therapeutics AB ("XNK") today announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie Invest AB. The purpose of the issue is primarily to finance the company's clinical development in multiple myeloma and other indications.

Quick answer

Xnk Therapeutics Ab raised SEK132 Million in a Funding Round round, dated March 29, 2022. Xnk Therapeutics Ab is based in Flemingsberg, Stockholms län, Sweden.

How much did Xnk Therapeutics Ab raise?
Xnk Therapeutics Ab raised SEK132 Million in a Funding Round round on March 29, 2022.
What does Xnk Therapeutics Ab do?
XNK Therapeutics is a clinical stage, immunotherapy company focusing its efforts on preventing and treating cancer by developing novel NK cell-based therapies.
Where is Xnk Therapeutics Ab based and how big is it?
Xnk Therapeutics Ab is based in Flemingsberg, Stockholms län, Sweden.
Who are the decision-makers at Xnk Therapeutics Ab?
Fundz holds 1 contact at Xnk Therapeutics Ab. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Xnk Therapeutics Ab, and when

A new round usually means Xnk Therapeutics Ab is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xnk Therapeutics Ab raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xnk Therapeutics Ab, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xnk Therapeutics Ab. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xnk Therapeutics Ab

Location

Flemingsberg, Stockholms län, Sweden

About

XNK Therapeutics is a clinical stage, immunotherapy company focusing its efforts on preventing and treating cancer by developing novel NK cell-based therapies. The company is at the forefront of the development of autologous NK cell-based products using its proprietary technology platform. The company's platform technology and lead investigational candidate drug was developed specifically to target cancers, including settings where allogeneic cell products are not readily applicable. The Company's objective is for its investigational candidate drug and proprietary platform technology to constitute key components in the cancer treatments of tomorrow. XNK Therapeutics is headquartered in Stockholm, Sweden. For more information, please visit www.xnktherapeutics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xnk Therapeutics Ab raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Xnk Therapeutics Ab's next move

See what Strategic adds

Xnk Therapeutics Ab raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.